Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC): Outcomes from a community oncology network.

被引：0
|
作者：
Neubauer, M. A.
Garey, J. S.
Nelson, G. C.
Patt, D. A.
Cartwright, T. H.
Hoverman, J. R.
Busby, L. T.
Brooks, B. D.
Sitarik, M. A.
Kolodziej, M. A.
Anderson, R. W.
Beveridge, R. A.
机构：
[1] US Oncol, Kansas City Canc Ctr, The Woodlands, TX USA
[2] US Oncol Pathways Task Force, The Woodlands, TX USA
[3] US Oncol, The Woodlands, TX USA
[4] Ocala Oncol, Ocala, FL USA
[5] US Oncol, Texas Oncol, The Woodlands, TX USA
[6] US Oncol, Rocky Mt Canc Ctr, Boulder, CO USA
[7] US Oncol, New York Hematol Oncol, Albany, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e16527
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16527
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Bevacizumab (BV) Treatment to Progression (BTP) in Non-small Cell Lung Cancer (NSCLC): Outcomes From a US Community Practice Network
    Nadler, E.
    Yu, E.
    Ravelo, A.
    Sing, A.
    Forsyth, M.
    Gruschkus, S.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S515 - S515
  • [2] In vivo assessment of the effects of bevacizumab in advanced non-small cell lung cancer (NSCLC)
    Heist, R. S.
    Duda, G. D.
    Sahani, D.
    Pennell, N. A.
    Neal, J. W.
    Ancukiewicz, M.
    Engelman, J. A.
    Lynch, T. J.
    Jain, R. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumab
    Stinchcombe, Thomas E.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (03): : 185 - 194
  • [4] Advanced Non-Small Cell Lung Cancer (NSCLC): Maintenance Therapy for All?
    Nooshin Hashemi-Sadraei
    Nathan A. Pennell
    Current Treatment Options in Oncology, 2012, 13 : 478 - 490
  • [5] Advanced Non-Small Cell Lung Cancer (NSCLC): Maintenance Therapy for All?
    Hashemi-Sadraei, Nooshin
    Pennell, Nathan A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (04) : 478 - 490
  • [6] The therapy of locally advanced non-small cell lung cancer (NSCLC) in the elderly
    Schild, S. E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S7 - S7
  • [7] Exclusions to use of bevacizumab in elderly veterans with advanced non-small cell lung cancer (NSCLC)
    Merza, T.
    Howard, L. M.
    Junagadhwalla, M.
    Gajra, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    LUNG CANCER, 2002, 38 : S47 - S50
  • [9] Effectiveness of Bevacizumab (BV) Maintenance in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Treated in US Community Practices
    Thomas, S.
    Ravelo, A.
    Yu, E.
    Dranitsaris, G.
    Kalberer, T.
    Beegle, N.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S618 - S618
  • [10] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345